Expression of the folate receptor is elevated in many cancers, rendering it a valuable target for tumor‐specific drug delivery.[39] According to the GEPIA2 database, PDAC also demonstrated significant upregulation of folate receptor alpha (FOLR1) (Figure S4A, Supporting Information). This evidence concerns the gene FOLR1 and neoplasm.